Study details
Enrolling now
MAD Study of IA-14069
ILAb Co., Ltd.
NCT IDNCT05533372ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
75
Study length
about 3.4 years
Ages
18–70
Locations
1 site in KS
What this study is about
This trial is testing a treatment called IA-14069. It's being done in healthy volunteers and people with rheumatoid arthritis (RA). The goal is to see how safe, well-tolerated, and effective the treatment is.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take IA-14069
- 2.Take Methotrexate
- 3.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
methotrexate
Drug routes
oral (Oral Tablet)
Endpoints
Primary: Incidnece and severity of adverse events
Secondary: AUC, Cmax, Tmax
Body systems
Immune